Minimally Invasive Surgery Market to Grow from USD 94.45 Billion in 2025 to USD 199.30 Billion by 2030, at a CAGR of 16.1% – MarketsandMarkets™

Delray Beach, FL, Aug. 12, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global minimally invasive surgery market will grow from USD 94.45 billion in 2025 to USD 199.30 billion by 2030, at a CAGR of 16.1% during the forecast period. Market growth is fueled by the increasing preference for minimally invasive procedures that offer faster recovery, shorter hospital stays, less postoperative pain, and improved clinical outcomes. Continuous advancements in robotic-assisted surgery, AI-enabled imaging, 3D visualization, precision surgical instruments, and image-guided technologies are further accelerating adoption across multiple surgical specialties. Rising chronic disease prevalence, expanding geriatric populations, increasing outpatient surgical procedures, and growing healthcare infrastructure investments are expected to further strengthen market growth worldwide.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=787

Key Market Highlights

• Market size, 2025: USD 94.45 billion
• Market forecast, 2030: USD 199.30 billion
• Growth rate: CAGR of 16.1% (2025–2030)
• Fastest-growing region: Asia Pacific
• Fastest-growing product segment: Imaging & visualization systems
• Largest imaging segment: Ultrasound systems
• Fastest-growing application: Urological surgery
• Largest application: Gastrointestinal & abdominal surgery
• Major growth drivers: Rising adoption of minimally invasive surgery over open surgery, robotic-assisted technologies, AI-enabled imaging, and increasing outpatient procedures
• Leading companies: Medtronic (Ireland), Johnson & Johnson (US), Stryker (US), Boston Scientific Corporation (US), Siemens Healthineers AG (Germany), Zimmer Biomet (US), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Intuitive Surgical Operations, Inc. (US), FUJIFILM Corporation (Japan), Olympus Corporation (Japan), Smith+Nephew (UK), KARL STORZ SE & Co. KG (Germany), and B. Braun SE (Germany).

Why This Market Matters

Minimally invasive surgery has transformed modern healthcare by enabling surgeons to perform complex procedures through smaller incisions while reducing surgical trauma, postoperative pain, infection risk, and recovery time. As healthcare providers increasingly focus on improving patient outcomes and reducing treatment costs, minimally invasive procedures are becoming the preferred alternative to conventional open surgeries across specialties including gastrointestinal, gynecological, urological, orthopedic, cardiothoracic, neurological, and oncological surgery. Continuous innovation in robotics, advanced visualization systems, precision instruments, and AI-assisted navigation is further expanding the scope and effectiveness of minimally invasive interventions.

Market Overview

The minimally invasive surgery market continues to experience rapid expansion as hospitals, specialty clinics, and ambulatory surgical centers increasingly invest in advanced surgical technologies to improve clinical efficiency and patient outcomes. The market is evolving through the adoption of robotic-assisted surgery, advanced imaging systems, endoscopic technologies, electrosurgical devices, and integrated digital surgical platforms. While high capital investment, lengthy purchasing cycles, reimbursement uncertainties, and evolving regulatory requirements remain key challenges, ongoing technological innovation and expanding healthcare infrastructure continue to support long-term market growth.

Analyst Perspective

The future of minimally invasive surgery lies in intelligent surgical ecosystems that combine robotics, artificial intelligence, advanced visualization, digital navigation, and real-time clinical data. As ambulatory surgical centers increasingly adopt robotic-assisted procedures and healthcare systems continue shifting toward value-based care, manufacturers are investing in compact robotic platforms, software-driven surgical guidance, digital workflow integration, and surgeon training programs. Companies that successfully combine precision technologies with affordability and workflow efficiency are expected to strengthen their competitive positions during the coming decade.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=787

Segment Analysis

By product, imaging & visualization systems are expected to register the highest growth during the forecast period. Within this category, ultrasound systems accounted for the largest market share in 2024 owing to their real-time imaging capabilities, radiation-free operation, affordability, portability, and expanding applications across multiple minimally invasive procedures.

By application, the urological surgery segment is projected to witness the highest CAGR during the forecast period due to the increasing prevalence of prostate cancer, bladder cancer, renal disorders, and growing adoption of laparoscopic and robotic-assisted urological procedures. Meanwhile, gastrointestinal & abdominal surgery continues to account for the largest application share in the minimally invasive surgery market.

Regional Analysis

The Asia Pacific region is expected to register the highest CAGR during the forecast period, driven by rapidly aging populations, increasing prevalence of chronic diseases, expanding healthcare infrastructure, rising government investments, and growing adoption of advanced surgical technologies. Countries such as China and India are witnessing substantial increases in laparoscopic procedures and robotic-assisted surgeries as hospitals continue modernizing surgical capabilities and improving access to minimally invasive treatment options.

Key Industry Trends

• Increasing adoption of robotic-assisted minimally invasive surgery
• Growing integration of AI-enabled imaging and surgical navigation
• Rising demand for outpatient minimally invasive procedures
• Expansion of robotic platforms across ambulatory surgical centers
• Increasing adoption of advanced ultrasound and real-time visualization systems
• Growing investment in digital surgical ecosystems and precision surgery
• Continuous innovation in endoscopy, electrosurgery, and medical robotics

Competitive Landscape

The minimally invasive surgery market is moderately consolidated, with the leading five companies collectively accounting for 25%–50% of the global market. Major market participants include Medtronic (Ireland), Johnson & Johnson (US), Siemens Healthineers AG (Germany), Zimmer Biomet (US), Intuitive Surgical Operations, Inc. (US), Stryker (US), Boston Scientific Corporation (US), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Olympus Corporation (Japan), Smith+Nephew (UK), KARL STORZ SE & Co. KG (Germany), Teleflex Incorporated (US), CooperSurgical, Inc. (US), CONMED Corporation (US), Getinge AB (Sweden), Globus Medical, Inc. (US), and B. Braun SE (Germany). Companies continue strengthening their market positions through product innovation, acquisitions, regulatory approvals, strategic collaborations, and expansion of robotic-assisted surgical technologies.

Related Reports
Surgical Robots Market
Endoscopy Equipment Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Report Code: MD 1250 | Published: 29 July 2025 | Report Pages: 450 | Market Data Tables: 400 | Figures: 60